Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, March 23, 2015, 74 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $987.00 to $64,149,572.70.

Highlighted Stocks Traded by Insiders:

Repligen (RGEN) - FREE Research Report

Herlihy Walter C, who is President And Ceo at Repligen, sold 24,536 shares at $31.78 on March 23, 2015. Following this transaction, the President And Ceo owned 422,430 shares meaning that the stake was reduced by 5.49% with the 24,536-share transaction.

The shares most recently traded at $31.83, up $0.05, or 0.15% since the insider transaction. Historical insider transactions for Repligen go as follows:

  • 4-Week # shares bought: 35,000
  • 4-Week # shares sold: 61,683
  • 12-Week # shares bought: 35,000
  • 12-Week # shares sold: 61,683
  • 24-Week # shares bought: 35,000
  • 24-Week # shares sold: 150,411

The average volume for Repligen has been 382,100 shares per day over the past 30 days. Repligen has a market cap of $1.1 billion and is part of the health care sector and drugs industry. Shares are up 60.35% year-to-date as of the close of trading on Monday.

Repligen Corporation, a life sciences company, develops, manufactures, and markets consumable bioprocessing products for use in the production of monoclonal antibodies and other biologic drugs. The company has a P/E ratio of 129.3. Currently, there are 2 analysts who rate Repligen a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RGEN - FREE

TheStreet Quant Ratings rates Repligen as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Repligen Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Ferrellgas Partners (FGP) - FREE Research Report

Kaye Daniel G, who is Director at Ferrellgas Partners, bought 1,000 shares at $22.25 on March 23, 2015. Following this transaction, the Director owned 3,000 shares meaning that the stake was boosted by 50% with the 1,000-share transaction.

The shares most recently traded at $22.16, down $0.09, or 0.41% since the insider transaction. Historical insider transactions for Ferrellgas Partners go as follows:

  • 4-Week # shares bought: 9,200
  • 12-Week # shares bought: 10,200
  • 24-Week # shares bought: 26,140

The average volume for Ferrellgas Partners has been 202,500 shares per day over the past 30 days. Ferrellgas Partners has a market cap of $1.8 billion and is part of the basic materials sector and energy industry. Shares are up 0.68% year-to-date as of the close of trading on Monday.

Ferrellgas Partners, L.P. distributes and sells propane and related equipment and supplies primarily in the United States. The company transports propane to propane distribution locations, tanks on customers' premises, or to portable propane tanks delivered to retailers. The stock currently has a dividend yield of 8.99%. The company has a P/E ratio of 37.7. Currently, there are no analysts who rate Ferrellgas Partners a buy, 4 analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on FGP - FREE

TheStreet Quant Ratings rates Ferrellgas Partners as a hold. The company's strengths can be seen in multiple areas, such as its increase in net income, good cash flow from operations and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and poor profit margins. Get the full Ferrellgas Partners Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Pericom Semiconductor (PSEM) - FREE Research Report

Hui Chi Hung, who is Sr.Vice President, R & D at Pericom Semiconductor, sold 698 shares at $16.00 on March 23, 2015. Following this transaction, the Sr.Vice President, R & D owned 738,236 shares meaning that the stake was reduced by 0.09% with the 698-share transaction.

Historical insider transactions for Pericom Semiconductor go as follows:

  • 4-Week # shares sold: 80,000
  • 12-Week # shares sold: 150,504
  • 24-Week # shares sold: 201,314

The average volume for Pericom Semiconductor has been 143,000 shares per day over the past 30 days. Pericom Semiconductor has a market cap of $359.3 million and is part of the technology sector and electronics industry. Shares are up 19.57% year-to-date as of the close of trading on Monday.

Pericom Semiconductor Corporation designs, manufactures, and markets high-performance digital, analog, and mixed-signal integrated circuits (ICs); and frequency control products (FCPs) used in electronic systems worldwide. The stock currently has a dividend yield of 0.37%. The company has a P/E ratio of 42.3. Currently, there are 2 analysts who rate Pericom Semiconductor a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PSEM - FREE

TheStreet Quant Ratings rates Pericom Semiconductor as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Pericom Semiconductor Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null